Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-19

Clinical Trial Update: The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China

View source ↗

Summary

An AstraZeneca-sponsored study in China reports the asthma control rate achieved with budesonide/formoterol in real-world clinical practice. The update highligh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide/Formoterol (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED